In this study, we tested the effects of targeting the PI3K pathway using the triple DNA-PK/PI3K/mTOR inhibitor PI-103 in combination with IR to induce radiosensitization in two GBM cell lines differing in DNA-PK function [29]. This evidence concerns the gene MTOR and glioblastoma.